Catalent is cutting more roles at its gene therapy manufacturing facility in Harmans, Maryland. This round of layoffs will affect 93 employees and will be effective on March 19, according to a Maryland Work Adjustment and Retraining Notification (WARN) filing.
The state's WARN report also notes the CDMO's dismissal of three other employees in nearby Baltimore.
https://www.fiercepharma.com/manufacturing/catalent-cuts-staff-96-another-round-layoffs-maryland